Form 13-F position report

* DOLBY LABORATORIES INC

Reported by BAILLIE GIFFORD & CO

DLB CUSIP 25659T107 Manager CIK 0001088875

Reported 381,212 shares, up 25,536 (7.2%) from the prior quarter.

Reported value -12.0%; share count 7.2% vs. the prior quarter.

Added
% of reported 13F value 0.02% This manager · Q1 2022
Shares 381,212 Quarter-end amount reported
Reported value $29,818,000 Fair value at quarter end
Consecutive quarters held 36 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 33867000
2022-03-31 29818000
2022-06-30 36004000
2022-09-30 33940000
2022-12-31 44061824
2023-03-31 58545501
2023-06-30 55976815
2023-09-30 42144840
2023-12-31 40983072
2024-03-31 38741363
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by BAILLIE GIFFORD & CO.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -462,473 (-100.0%) 0 $0 2024-07-25
Q1 2024 Reduced 462,473 -13,079 (-2.8%) 0.03% $38,741,363 2024-05-01
Q4 2023 Reduced 475,552 -56,177 (-10.6%) 0.03% $40,983,072 2024-01-26
Q3 2023 Reduced 531,729 -137,210 (-20.5%) 0.04% $42,144,840 2023-11-13
Q2 2023 Reduced 668,939 -16,445 (-2.4%) 0.05% $55,976,815 2023-07-28
Q1 2023 Added 685,384 +60,748 (9.7%) 0.05% $58,545,501 2023-05-03
Q4 2022 Added 624,636 +103,683 (19.9%) 0.05% $44,061,824 2023-01-24
Q3 2022 Added 520,953 +17,818 (3.5%) 0.03% $33,940,000 2022-10-27
Q2 2022 Added 503,135 +121,923 (32.0%) 0.04% $36,004,000 2022-08-08
Q1 2022 Added 381,212 +25,536 (7.2%) 0.02% $29,818,000 2022-05-05
Q4 2021 Added 355,676 +43,572 (14.0%) 0.02% $33,867,000 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

401 managers reported * DOLBY LABORATORIES INC for Q1 2022.

Managers reporting * DOLBY LABORATORIES INC in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,257,157 +99,453 0.01% $489,435,000 36 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Added 3,747,973 +222,677 1.09% $293,166,000 9 qtrs
Jackson Square Partners LLC Added 3,381,430 +153,074 2.63% $264,495,000 6 qtrs
Clearbridge Investments LLC Reduced 3,318,614 -54,073 0.2% $259,582,000 36 qtrs
BlackRock Inc Reduced 3,123,846 -303,577 < 0.01% $244,349,000 36 qtrs
Ninety One UK Ltd Added 2,722,534 +1,036,041 0.54% $212,957,000 3 qtrs
SOMA EQUITY PARTNERS LP Unchanged 2,300,000 0 5.96% $179,906,000 7 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Added 1,868,995 +731,900 0.39% $146,193,000 8 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Added 1,778,339 +144,335 0.03% $139,101,000 36 qtrs
JANUS HENDERSON GROUP PLC Reduced 1,619,550 -346,768 0.06% $126,682,000 24 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 05, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
378,345
Shared
0
None
2,867

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.